KR102050299B1 - 다한증 치료용 항콜린성 글리코피롤레이트 에스테르 - Google Patents

다한증 치료용 항콜린성 글리코피롤레이트 에스테르 Download PDF

Info

Publication number
KR102050299B1
KR102050299B1 KR1020157028470A KR20157028470A KR102050299B1 KR 102050299 B1 KR102050299 B1 KR 102050299B1 KR 1020157028470 A KR1020157028470 A KR 1020157028470A KR 20157028470 A KR20157028470 A KR 20157028470A KR 102050299 B1 KR102050299 B1 KR 102050299B1
Authority
KR
South Korea
Prior art keywords
composition
hydroxyacetoxy
cyclopentyl
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157028470A
Other languages
English (en)
Korean (ko)
Other versions
KR20150128942A (ko
Inventor
니콜라스 에스. 보도르
데이비드 앙굴로
Original Assignee
보도르 라보래토리즈, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50625156&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102050299(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 보도르 라보래토리즈, 인크. filed Critical 보도르 라보래토리즈, 인크.
Publication of KR20150128942A publication Critical patent/KR20150128942A/ko
Application granted granted Critical
Publication of KR102050299B1 publication Critical patent/KR102050299B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
KR1020157028470A 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르 Active KR102050299B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798073P 2013-03-15 2013-03-15
US61/798,073 2013-03-15
PCT/US2014/028332 WO2014144075A1 (en) 2013-03-15 2014-03-14 Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197034502A Division KR102153457B1 (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르

Publications (2)

Publication Number Publication Date
KR20150128942A KR20150128942A (ko) 2015-11-18
KR102050299B1 true KR102050299B1 (ko) 2019-11-29

Family

ID=50625156

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020157028470A Active KR102050299B1 (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르
KR1020197034502A Active KR102153457B1 (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르
KR1020217010876A Ceased KR20210043742A (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르
KR1020207015539A Active KR102241660B1 (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020197034502A Active KR102153457B1 (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르
KR1020217010876A Ceased KR20210043742A (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르
KR1020207015539A Active KR102241660B1 (ko) 2013-03-15 2014-03-14 다한증 치료용 항콜린성 글리코피롤레이트 에스테르

Country Status (22)

Country Link
US (5) US9220707B2 (enExample)
EP (1) EP2968267B1 (enExample)
JP (4) JP6223543B2 (enExample)
KR (4) KR102050299B1 (enExample)
CN (2) CN105050596A (enExample)
AU (1) AU2014227923B2 (enExample)
BR (1) BR112015023153A2 (enExample)
CA (1) CA2904724C (enExample)
DK (1) DK2968267T3 (enExample)
ES (1) ES2673098T3 (enExample)
HK (1) HK1217177A1 (enExample)
HU (1) HUE038448T2 (enExample)
IL (1) IL241307B (enExample)
MX (1) MX363601B (enExample)
MY (1) MY192033A (enExample)
PH (1) PH12015501987A1 (enExample)
PL (1) PL2968267T3 (enExample)
PT (1) PT2968267T (enExample)
SG (1) SG11201507602SA (enExample)
TR (1) TR201808040T4 (enExample)
WO (1) WO2014144075A1 (enExample)
ZA (1) ZA201506834B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6223543B2 (ja) * 2013-03-15 2017-11-01 ボドール ラボラトリーズ， インコーポレイテッド 多汗症の処置のための抗コリン作用性グリコピロレートエステル
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
US20150259283A1 (en) * 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
JP6387458B2 (ja) * 2015-04-30 2018-09-05 久光製薬株式会社 多汗症治療用外用剤
US20180228770A1 (en) * 2015-07-21 2018-08-16 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
US20180235869A1 (en) * 2015-09-11 2018-08-23 Bodor Laboratories, Inc. Methods and compositions for soft anticholinergic zwitterions
MY197265A (en) * 2015-09-11 2023-06-08 Bodor Laboratories Inc Methods and compositions for soft anticholinergic esters
CA3029621A1 (en) * 2016-07-01 2018-01-04 Bodor Laboratories, Inc. Compositions and methods for treatment of copd
TWI719046B (zh) 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
KR101951021B1 (ko) 2017-02-06 2019-02-22 주식회사 퍼슨 발한억제 기능을 가지는 자외선 차단 화장료 조성물 및 이를 사용한 자외선 차단제의 제조방법
DK3431072T3 (da) * 2017-07-17 2020-02-17 Dr August Wolff Gmbh & Co Kg Arzneimittel Olie-i-vand-emulsion
EP3826631A1 (en) 2018-07-24 2021-06-02 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical emulsion of an anticholinergic compound
SG10201912063PA (en) * 2019-12-12 2021-07-29 Nat Skin Centre Singapore Pte Ltd A pharmaceutical formulation
TW202146010A (zh) 2020-03-03 2021-12-16 日商科研製藥股份有限公司 原發性腋窩多汗症的治療方法及其醫藥
US20230149349A1 (en) 2020-03-03 2023-05-18 Kaken Pharmaceutical Co., Ltd. Medicament containing sofpironium bromide
EP4333831B1 (en) 2022-04-14 2024-08-14 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical formulation of an anticholinergic compound for treating severe hyperhidrosis and excessive sweating
EP4260852A1 (en) 2022-04-14 2023-10-18 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical formulation of an anticholinergic compound for treating severe hyperhidrosis and excessive sweating
KR102611847B1 (ko) * 2023-03-27 2023-12-12 주식회사 이플라스크 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058971A2 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
WO2009051818A1 (en) 2007-10-18 2009-04-23 Stiefel Research Australia Pty Ltd Topical glycopyrrolate formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292530A (en) 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
EP1438001A4 (en) 2001-09-26 2006-03-15 Alison B Lukacsko COMPOSITIONS AND METHODS FOR INHIBITING ECCRINS PERSPIRATION IN HUMANS
US8252316B2 (en) 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428418D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
US7399861B2 (en) 2005-11-10 2008-07-15 Bodor Nicholas S Soft anticholinergic esters
US8071693B2 (en) 2006-06-22 2011-12-06 Sabic Innovative Plastics Ip B.V. Polysiloxane/polyimide copolymers and blends thereof
JP6223543B2 (ja) * 2013-03-15 2017-11-01 ボドール ラボラトリーズ， インコーポレイテッド 多汗症の処置のための抗コリン作用性グリコピロレートエステル

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058971A2 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
WO2009051818A1 (en) 2007-10-18 2009-04-23 Stiefel Research Australia Pty Ltd Topical glycopyrrolate formulations

Also Published As

Publication number Publication date
DK2968267T3 (en) 2018-06-25
MY192033A (en) 2022-07-24
JP2016517431A (ja) 2016-06-16
KR102153457B1 (ko) 2020-09-08
US20140275204A1 (en) 2014-09-18
IL241307A0 (en) 2015-11-30
US20190328707A1 (en) 2019-10-31
US20160310464A1 (en) 2016-10-27
CN105050596A (zh) 2015-11-11
SG11201507602SA (en) 2015-10-29
ZA201506834B (en) 2018-12-19
KR20190133072A (ko) 2019-11-29
KR20200065103A (ko) 2020-06-08
JP6694908B2 (ja) 2020-05-20
EP2968267B1 (en) 2018-04-25
CA2904724A1 (en) 2014-09-18
US20180185331A1 (en) 2018-07-05
MX363601B (es) 2019-03-28
JP7008988B2 (ja) 2022-01-25
MX2015012072A (es) 2016-05-05
CN109364066A (zh) 2019-02-22
US9492429B2 (en) 2016-11-15
HK1217177A1 (zh) 2016-12-30
PT2968267T (pt) 2018-06-15
CA2904724C (en) 2021-01-26
IL241307B (en) 2019-07-31
WO2014144075A1 (en) 2014-09-18
PL2968267T3 (pl) 2018-09-28
ES2673098T3 (es) 2018-06-19
HK1220369A1 (en) 2017-05-05
US10772867B2 (en) 2020-09-15
AU2014227923B2 (en) 2019-02-14
AU2014227923A1 (en) 2015-10-08
KR20150128942A (ko) 2015-11-18
TR201808040T4 (tr) 2018-06-21
US20160067214A1 (en) 2016-03-10
JP2018115187A (ja) 2018-07-26
KR20210043742A (ko) 2021-04-21
EP2968267A1 (en) 2016-01-20
US9220707B2 (en) 2015-12-29
JP2020122002A (ja) 2020-08-13
KR102241660B1 (ko) 2021-04-19
JP6461214B2 (ja) 2019-01-30
BR112015023153A2 (pt) 2017-07-18
US10383846B2 (en) 2019-08-20
US9895350B2 (en) 2018-02-20
JP2017105811A (ja) 2017-06-15
PH12015501987A1 (en) 2016-01-11
HUE038448T2 (hu) 2018-10-29
WO2014144075A8 (en) 2015-10-15
JP6223543B2 (ja) 2017-11-01

Similar Documents

Publication Publication Date Title
KR102050299B1 (ko) 다한증 치료용 항콜린성 글리코피롤레이트 에스테르
KR102433868B1 (ko) 연성 항콜린성 유사체를 위한 제제
CN108137612A (zh) 软性抗胆碱能药类似物的制剂
HK1220369B (en) Soft anticholinergic esters for the treatment of hyperhidrosis
HK40026881B (en) Formulation for soft anticholinergic analogs
HK40016903B (en) Formulation for soft anticholinergic analogs
BR112018001262B1 (pt) Composição tópica e usos de uma composição

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20151012

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190314

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20190314

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190410

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190703

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20190410

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20190703

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20190610

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20190314

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20190826

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20190802

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20190703

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20190610

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20190314

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20191122

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20191125

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20191126

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20221017

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20231017

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20241016

Start annual number: 6

End annual number: 6